$ISPR
Ispire Technology Inc. Stock $ispr

$ispr Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000121390023077437 Filed on September 19, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$42.86M	$32.63M	$115.6M
YoY Change	59.09%	-62.96%	31.23%
Cost Of Revenue	$35.98M	$26.00M	$94.53M
YoY Change	62.41%	-65.23%	26.39%
Gross Profit	$6.888M	$6.625M	$21.08M
YoY Change	43.74%	-50.21%	58.39%
Gross Profit Margin	16.07%	20.3%	18.23%
Selling, General & Admin	$7.800M	$6.054M	$25.64M
YoY Change	29.84%	-57.65%	79.4%
% of Gross Profit	113.23%	91.39%	121.68%
Research & Development			$146.1K
YoY Change
% of Gross Profit			0.69%
Depreciation & Amortization	$29.12K	$25.78K	$46.66K
YoY Change	344.14%	173.67%	348.65%
% of Gross Profit	0.42%	0.39%	0.22%
Operating Expenses	$7.800M	$6.054M	$25.64M
YoY Change	29.84%	-57.65%	79.4%
Operating Profit	-$911.3K	$570.6K	-$4.569M
YoY Change	-24.99%	-157.71%	362.15%
Interest Expense	$75.91K	-$389.4K	-$129.0K
YoY Change		-715.94%	-304.08%
% of Operating Profit		-68.25%
Other Income/Expense, Net	-$43.20K	-$46.71K	-$284.2K
YoY Change		-138.16%	-332.18%
Pretax Income	-$878.6K	$134.5K	-$4.853M
YoY Change		-116.75%	504.35%
Income Tax	$496.1K	$175.3K	$1.245M
% Of Pretax Income		130.35%
Net Earnings	-$1.375M	-$40.83K	-$6.099M
YoY Change	-31.33%	-97.82%	225.41%
Net Earnings / Revenue	-3.21%	-0.13%	-5.28%
Basic Earnings Per Share	-$0.03		-$0.12
Diluted Earnings Per Share	-$0.03	$0.00	-$0.12
COMMON SHARES
Basic Shares Outstanding	54.86M shares	53.11M shares	50.73M shares
Diluted Shares Outstanding	54.25M shares		50.73M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.88M	$49.43M	$49.43M
YoY Change			-33.63%
Cash & Equivalents	$25.69M	$40.30M
Short-Term Investments	$9.193M	$9.134M	$9.134M
Other Short-Term Assets	$1.720M	$3.379M	$3.251M
YoY Change			4895.42%
Inventory	$5.609M	$7.472M	$7.472M
Prepaid Expenses
Receivables	$39.16M	$24.53M	$24.53M
Other Receivables	$244.9K	$127.6K	$127.6K
Total Short-Term Assets	$81.61M	$84.81M	$84.81M
YoY Change		-14.72%	-14.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.592M	$1.088M	$5.150M
YoY Change		854.29%	1156.56%
Goodwill
YoY Change
Intangibles	$255.7K	$0.00
YoY Change
Long-Term Investments			$0.00
YoY Change
Other Assets	$6.793M	$5.882M	$732.3K
YoY Change		357.42%	-16.41%
Total Long-Term Assets	$6.793M	$5.882M	$5.882M
YoY Change		357.42%	357.42%
TOTAL ASSETS
Total Short-Term Assets	$81.61M	$84.81M	$84.81M
Total Long-Term Assets	$6.793M	$5.882M	$5.882M
Total Assets	$88.41M	$90.69M	$90.69M
YoY Change		-9.97%	-9.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.68M	$1.274M	$52.97M
YoY Change		338.63%	25.31%
Accrued Expenses	$17.31K	$35.85K	$1.078M
YoY Change		3.66%	153.21%
Deferred Revenue	$1.290M	$988.6K
YoY Change		-40.88%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.01M	$55.96M	$55.96M
YoY Change		-37.1%	-37.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.388M	$3.356M	$3.356M
YoY Change
Total Long-Term Liabilities	$3.388M	$3.356M	$3.356M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.01M	$55.96M	$55.96M
Total Long-Term Liabilities	$3.388M	$3.356M	$3.356M
Total Liabilities	$57.39M	$59.32M	$59.32M
YoY Change		-33.33%	-33.33%
SHAREHOLDERS EQUITY
Retained Earnings	$4.473M	$5.848M
YoY Change		-51.05%
Common Stock	$5.427K	$5.422K
YoY Change		8.44%
Preferred Stock		$7.426M
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.01M	$31.37M	$31.37M
YoY Change
Total Liabilities & Shareholders Equity	$88.41M	$90.69M	$90.69M
YoY Change		-9.97%	-9.97%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$1.375M	-$40.83K	-$6.099M
YoY Change	-31.33%	-97.82%	225.41%
Depreciation, Depletion And Amortization	$29.12K	$25.78K	$46.66K
YoY Change	344.14%	173.67%	348.65%
Cash From Operating Activities	-$12.88M	-$9.833M	-$7.582M
YoY Change	-676.08%	-1383.96%	0.32%
INVESTING ACTIVITIES
Capital Expenditures	$533.1K	$525.7K	$1.021M
YoY Change	64.17%	608.78%	740.0%
Acquisitions
YoY Change
Other Investing Activities		$470.7K	-$9.134M
YoY Change
Cash From Investing Activities	-$788.8K	-$55.00K	-$10.15M
YoY Change	142.89%	-25.85%	8256.22%
FINANCING ACTIVITIES
Cash Dividend Paid			$3.363M
YoY Change			616.01%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$945.5K	26.15M	-$16.44M
YoY Change	224.52%	-3864.01%	432.29%
NET CHANGE
Cash From Operating Activities	-$12.88M	-9.833M	-$7.582M
Cash From Investing Activities	-$788.8K	-55.00K	-$10.15M
Cash From Financing Activities	-$945.5K	26.15M	-$16.44M
Net Change In Cash	-$14.61M	16.26M	-$34.18M
YoY Change	-1002.28%	-519747.28%	217.41%
FREE CASH FLOW
Cash From Operating Activities	-$12.88M	-$9.833M	-$7.582M
Capital Expenditures	$533.1K	$525.7K	$1.021M
Free Cash Flow	-$13.41M	-$10.36M	-$8.603M
YoY Change	-801.87%	-1597.64%	12.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41680
CY2023	dei	Entity Registrant Name EntityRegistrantName	Ispire Technology Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-1869878
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	19700 Magellan Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90502
CY2023	dei	City Area Code CityAreaCode	(310)
CY2023	dei	Local Phone Number LocalPhoneNumber	742-9975
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	ISPR
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54856231	shares
CY2023	dei	Auditor Firm AuditorFirmId	717
CY2023	dei	Auditor Name AuditorName	MSPC
CY2023	dei	Auditor Location AuditorLocation	New York
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74480651	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40300573	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8260574	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24526262	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	14580557	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	7472108	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	192499	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3378617	usd
CY2022Q2	ispr	Due From Related Parties1 DueFromRelatedParties1	1934855	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	9133707	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	99449136	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	84811267	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	114025	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1088131	usd
CY2022Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	876100	usd
CY2023Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	732334	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	295804	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4061617	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1285929	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5882082	usd
CY2022Q2	us-gaap	Assets Assets	100735065	usd
CY2023Q2	us-gaap	Assets Assets	90693349	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	290541	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1274391	usd
CY2022Q2	ispr	Accounts Payable Related Party AccountsPayableRelatedParty	41982373	usd
CY2023Q2	ispr	Accounts Payable Related Party AccountsPayableRelatedParty	51698588	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1672051	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	988556	usd
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	3362639	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	159296	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	281361	usd
CY2022Q2	ispr	Due To Related Parties DueToRelatedParties	40672768	usd
CY2023Q2	ispr	Due To Related Parties DueToRelatedParties	710910	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	481113	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	63853	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347541	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	944525	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	88968322	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	55962184	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3356232	usd
CY2022Q2	us-gaap	Liabilities Liabilities	88968322	usd
CY2023Q2	us-gaap	Liabilities Liabilities	59318416	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54222420	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54222420	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	5422	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25685475	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-184664	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-163768	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11946407	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5847804	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11766743	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31374933	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	100735065	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90693349	usd
CY2022	us-gaap	Revenues Revenues	88095418	usd
CY2023	us-gaap	Revenues Revenues	115605536	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	74789378	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	94529769	usd
CY2022	us-gaap	Gross Profit GrossProfit	13306040	usd
CY2023	us-gaap	Gross Profit GrossProfit	21075767	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5503630	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4714923	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8791081	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20929978	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14294711	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	25644901	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-988671	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4569134	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	5078	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	195209	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	58143	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-324225	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	122394	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-155150	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	185615	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-284166	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-803056	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4853300	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1071097	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1245303	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1874153	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6098603	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-117085	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20896	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1991238	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6077707	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50725814	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13757981	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1874153	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-117085	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11766743	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6098603	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25685897	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	20896	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31374933	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1874153	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6098603	usd
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	10402	usd
CY2023	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	46662	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	135141	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1061442	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3332825	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3950508	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19579339	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11525561	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7108449	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-29007	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3088466	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8875590	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10574989	usd
CY2022	ispr	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	543890	usd
CY2023	ispr	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	-690637	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-282487	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	168179	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	481113	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-417260	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7557566	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7581759	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121516	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1020768	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	9133707	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121516	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10154475	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	21735000	usd
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	3475171	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7969221	usd
CY2023	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	543153	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	469633	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	3362639	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2498689	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	37893063	usd
CY2022	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	120942	usd
CY2023	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	874039	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3089264	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16443844	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10768346	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34180078	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85248997	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74480651	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74480651	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40300573	usd
CY2022	ispr	Cash Paidrefund For Income Taxes CashPaidrefundForIncomeTaxes	-69647	usd
CY2023	ispr	Cash Paidrefund For Income Taxes CashPaidrefundForIncomeTaxes	1663240	usd
CY2020Q3	us-gaap	Shares Issued SharesIssued	50000000	shares
CY2022Q4	us-gaap	Shares Issued SharesIssued	15000000	shares
CY2023Q2	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.003	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates include allowance for doubtful accounts, the useful lives of property and equipment and intangible asset, impairment of long-lived assets, and deferred cost. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Sale Leaseback Transaction Imputed Interest Rate SaleLeasebackTransactionImputedInterestRate	0.30	pure
CY2023	us-gaap	Sale Of Stock Percentage Of Ownership Before Transaction SaleOfStockPercentageOfOwnershipBeforeTransaction	0.70	pure
CY2023	us-gaap	Health Care Organization Allowance For Doubtful Accounts Percentage Of Accounts Receivable HealthCareOrganizationAllowanceForDoubtfulAccountsPercentageOfAccountsReceivable	0.80	pure
CY2023	ispr	Percentage Of Account Receivable PercentageOfAccountReceivable	0.10	pure
CY2023Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	9133707	usd
CY2023Q2	us-gaap	Investment Maturity Date InvestmentMaturityDate	2024-02-08
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	88095418	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	115605536	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	335677	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	298703	usd
CY2022	us-gaap	Interest Income Nontaxable Investment Security Increase Decrease InterestIncomeNontaxableInvestmentSecurityIncreaseDecrease	-10764	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50725814	shares
CY2023	us-gaap	Interest Income Nontaxable Investment Security Increase Decrease InterestIncomeNontaxableInvestmentSecurityIncreaseDecrease	-22378	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1455390	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2574664	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration and risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Risks and Uncertainties</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s business, financial condition and results of operations may be negatively impacted by risks related to government regulations, natural disasters, extreme weather conditions, health epidemics and other catastrophic incidents, which could significantly disrupt the Company’s operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Customer and Supplier Concentration</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) Customers</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended June 30, 2022 and 2023, the Company’s major customers, who accounted for more than 10% of the Company’s consolidated revenue, were as follow:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Major Customers</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">39</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">32</td><td style="width: 1%; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) Suppliers</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended June 30, 2022 and 2023, the Company’s suppliers, who accounted for more than 10% of the Company’s total purchases, were as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Major Suppliers</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B<sup>(1)</sup></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">99</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">92</td><td style="width: 1%; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major supplier B is Shenzhen Yi Jia, a Chinese company that is 95% owned by the Company’s chief executive officer and principal stockholder. See Note 13.</span></td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to credit risk from cash and cash equivalents, account receivables, financial assets included in prepayments and deposits and amounts due from related parties. All the Company’s cash and cash equivalents are held in major financial institutions located in Hong Kong and the United States, which management believes are of high credit quality. At June 30, 2022 and 2023, the Company had credit risk exposure of uninsured cash in banks of $74,000,991 and $39,792,081, respectively. The Company has policies in place to evaluate credit risk when accepting new business and to limit its credit exposure to individual customers. The management considers the Company does not have a significant concentration of credit risk. The Company does not require collateral to support financial instruments that are subject to credit risk.</p>
CY2023	ispr	Percentage Of Consolidated Revenue PercentageOfConsolidatedRevenue	0.10	pure
CY2022	ispr	Percentage Of Consolidated Revenue PercentageOfConsolidatedRevenue	0.10	pure
CY2023	ispr	Percentage Of Total Purchase PercentageOfTotalPurchase	0.10	pure
CY2022	ispr	Percentage Of Total Purchase PercentageOfTotalPurchase	0.10	pure
CY2023	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.95	pure
CY2022Q2	us-gaap	Credit Risk Derivatives At Fair Value Net CreditRiskDerivativesAtFairValueNet	74000991	usd
CY2023Q2	us-gaap	Credit Risk Derivatives At Fair Value Net CreditRiskDerivativesAtFairValueNet	39792081	usd
CY2022	ispr	Others Others	542	usd
CY2023	ispr	Others Others	-7047	usd
CY2022	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	1071097	usd
CY2023	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	1245303	usd
CY2022	ispr	Net Operating Losses NetOperatingLosses	8519617	usd
CY2022Q2	us-gaap	Cash Cash	74480651	usd
CY2023Q2	us-gaap	Cash Cash	40300573	usd
CY2022Q2	us-gaap	Cash Cash	74480651	usd
CY2023Q2	us-gaap	Cash Cash	40300573	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8260574	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	26025068	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1498806	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8260574	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24526262	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	3332825	usd
CY2023	ispr	Net Operating Losses NetOperatingLosses	14584702	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.80	pure
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1789120	usd
CY2023Q2	ispr	Prepaid Inventories PrepaidInventories	3209413	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	127423	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	127595	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	50460	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	26974	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	14616	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	14635	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	192499	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	3378617	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	433	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	518854	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	146798	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	339155	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	309990	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	147231	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1167999	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33206	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79868	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	114025	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1088131	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	11437	usd
CY2023	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	46629	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3062787	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1925780	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4500444	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3062787	usd
CY2022Q2	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	160009	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	0	usd
CY2022Q3	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	74259915	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1672051	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	988556	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1672051	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	295804	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4061617	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347541	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	944525	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3356232	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	347541	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4300757	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	667712	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1237868	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	304291	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1141142	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.058	pure
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.081	pure
CY2023	us-gaap	Loans And Leases Receivable Related Parties Additions LoansAndLeasesReceivableRelatedPartiesAdditions	200000	usd
CY2023Q2	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	981956	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	43487	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	97314	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	81226	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	148197	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34583	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35850	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	159296	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	281361	usd
CY2021Q2	ispr	Embedded Derivative Fair Values Of Embedded Derivative Liability EmbeddedDerivativeFairValuesOfEmbeddedDerivativeLiability	3832272	usd
CY2022Q2	ispr	Embedded Derivative Fair Values Of Embedded Derivative Liability EmbeddedDerivativeFairValuesOfEmbeddedDerivativeLiability	3362639	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	469633	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3362639	usd
CY2022Q2	ispr	Embedded Derivative Fair Values Of Embedded Derivative Liability EmbeddedDerivativeFairValuesOfEmbeddedDerivativeLiability	3362639	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1789120	usd
CY2022Q2	ispr	Due From Related Partie DueFromRelatedPartie	1934855	usd
CY2022Q2	ispr	Accounts Payable Related Parties AccountsPayableRelatedParties	41982373	usd
CY2023Q2	ispr	Accounts Payable Related Parties AccountsPayableRelatedParties	55769526	usd
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	74787679	usd
CY2023	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	83060957	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	2000000	hkd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-803056	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4853300	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-132504	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-800795	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-21142	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-21055	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-336712	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-553388	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Depletion IncomeTaxReconciliationNondeductibleExpenseDepletion	116287	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Depletion IncomeTaxReconciliationNondeductibleExpenseDepletion	61208	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	508980	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	23349	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	53279	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1925780	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4500444	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1925780	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4500444	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	375307	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1925780	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1550473	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2574664	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1925780	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4500444	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2700000	shares
CY2023Q2	us-gaap	Share Price SharePrice	7
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	ispr	Public Offering Price PublicOfferingPrice	405000	shares
CY2023Q2	ispr	Public Offering Price PublicOfferingPrice	405000	shares
CY2023Q2	us-gaap	Share Price SharePrice	7
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	21735000	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	3475171	usd
CY2023	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	311	usd
CY2023Q2	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	18259518	usd
CY2023Q2	ispr	Private Placement PrivatePlacement	1117420	shares
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.1318
CY2023Q2	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	7969221	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	543153	usd
CY2023Q2	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	111	usd
CY2023Q2	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	7425957	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1874153	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6098603	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50725814	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	ispr	Due From Related Parties1 DueFromRelatedParties1		usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2023Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent		usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022Q2	ispr	Prepaid Inventories PrepaidInventories		usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross		usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock		usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock		usd
CY2023Q2	ispr	Embedded Derivative Fair Values Of Embedded Derivative Liability EmbeddedDerivativeFairValuesOfEmbeddedDerivativeLiability		usd
CY2023Q2	ispr	Due From Related Partie DueFromRelatedPartie		usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50725814	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001948455
CY2022Q4	dei	Entity Public Float EntityPublicFloat	0	usd

Files In Submission

Name	View Source	Status
0001213900-23-077437-index-headers.html	Edgar Link	pending
0001213900-23-077437-index.html	Edgar Link	pending
0001213900-23-077437.txt	Edgar Link	pending
0001213900-23-077437-xbrl.zip	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
ex23-1_003.jpg	Edgar Link	pending
f10k2023ex23-1_ispiretech.htm	Edgar Link	pending
f10k2023ex31-1_ispiretech.htm	Edgar Link	pending
f10k2023ex31-2_ispiretech.htm	Edgar Link	pending
f10k2023ex32_ispiretech.htm	Edgar Link	pending
f10k2023_ispiretech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
ispr-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
ispr-20230630_cal.xml	Edgar Link	unprocessable
ispr-20230630_lab.xml	Edgar Link	unprocessable
ispr-20230630_pre.xml	Edgar Link	unprocessable
f10k2023_ispiretech_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ispr-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ISPR
Ispire Technology Inc. Stock $ispr

2023 Q3 Form 10-K Financial Statement

#000121390023077437 Filed on September 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISPR Ispire Technology Inc. Stock $ispr

2023 Q3 Form 10-K Financial Statement

#000121390023077437 Filed on September 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISPR
Ispire Technology Inc. Stock $ispr